Morphological subtyping of acute myeloid leukemia with maturation (AML-M2): Homogeneous pink-colored cytoplasm of mature neutrophils is most characteristic of AML-M2 with t(8;21)

Leukemia

Volumn 11, Issue 5, 1997, Pages 651-655

  Nakamura, H ^a   Kuriyama, K ^a   Sadamori, N ^a   Mine, M ^b   Itoyama, T ^a   Sasagawa, I ^a   Matsumoto, K ^b   Tsuji, Y ^b   Asou, N ^c   Kageyama, S I ^d   Sakamaki, H ^e   Emi, N ^f   Ohno, R ^g   Tomonaga, M ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d MIE UNIVERSITY   (Japan)

^e TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^f NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AML subtype M2; Cell morphology; t(8; 21)

Indexed keywords

MYELOPEROXIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CELL NUCLEUS; CELL ULTRASTRUCTURE; CHROMOSOME 21; CHROMOSOME 8; CHROMOSOME TRANSLOCATION; CYTOCHEMISTRY; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 16944363837     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400618     Document Type: Article

References (11)

1. Bitter MA, LeBeau MM, Rowley JD, Larson RA, Golomb HM, Vardiman JW. Associations between morphology, karyotype, and clinical features in myeloid leukemias. Hum Pathol 1987; 18: 211-225.
2. Swirsky DM, Li YS, Matthews JG, Flemans RJ, Rees JKH, Hayhoe FGJ. 8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features. Br J Haematol 1984; 56: 199-213.
3. Mitelman F. Catalog of Chromosome Aberrations in Cancer, 4th edn. John Wiley and Sons: New York, 1991.
4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103: 626-629.
5. Ohno R, Kobayashi T, Tanimoto M, Hiraoka A, Imai K, Asou N, Tomonaga M, Tsubaki K, Takahashi I, Kodera Y, Yoshida M, Murakami H, Naoe T, Shimoyama M, Tsukada T, Takeo T, Masaoka T, Onozavva Y, Fujimoto K, Kuriyama K, Horiuchi A, Kimura I, Minami S, Miura Y, Kageyama S, Tahara T, Teshima H, Shirakawa S, Saito H. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia: AML-87 Study of Japan Leukemia Study Group. Cancer 1993; 71: 3888-3895.
6. Brito-Babapulle F, Catovsky D, Galton DAG. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia. Br J Haematol 1987; 66: 445-450.
7. Tomonaga M, Sasaki T, Okuzaki M. Studies on leukocyte alkaline phosphatase. I. Use of the naphthol AS-MX phosphate-fast blue RR staining method. Acta Haematol Jpn 1963; 26: 179-192 (in Japanese).
8. van Lom K, Hagemeijer A, Vandekerckhove F, Smit EME, Löwenberg B. Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia. Br J Haematol 1996; 93: 594-600.
9. Nucifora G, Dickstein JI, Torbenson V, Roulston D, Rowley JD, Vardiman JW. Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Leukemia 1994; 8: 1533-1538.
10. Dastugue N, Payen C, Lafage-Pochitaloff M, Bernard P, Leroux D, Huguet-Rigal F, Stoppa A-M, Marit G, Molina L, Michallet M, Maraninchi D, Attal M, Reiffers J, for the BGMT group. Prognostic significance of karyotype in de novo adult acute myeloid leukemia. Leukemia 1995; 9: 1491-1498.
11. Nucifora G, Birn D, Erickson P, Gao J, LeBeau MM, Drabkin HA, Rowley JD. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) AML. Blood 1993; 81: 883-888.